Stuart Barnes
Internal Medicine · Anderson, SCNPI 1114106325
Payments from drug & device makers
Across 212 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$566
- Amgen$402
- AstraZeneca$382
- Novo Nordisk$344
- Pfizer$211
- Novartis$151
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,562100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 40 | $566 |
| Amgen | 16 | $402 |
| AstraZeneca | 20 | $382 |
| Novo Nordisk | 23 | $344 |
| Pfizer | 14 | $211 |
| Novartis | 9 | $151 |
| Bayer | 9 | $148 |
| AbbVie(2 entities) | 9 | $141 |
| Johnson & Johnson | 7 | $120 |
| GSK | 8 | $114 |
| Boehringer Ingelheim | 5 | $102 |
| Dexcom, Inc. | 7 | $101 |
| Idorsia Pharmaceuticals US Inc | 6 | $97 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $93 |
| Merck | 6 | $89 |
| Lundbeck LLC | 3 | $89 |
| Avanir Pharmaceuticals, Inc. | 4 | $65 |
| Abbott | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Clarus Therapeutics Inc. | 2 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Antares Pharma, Inc. | 1 | $20 |
| Circassia Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Halozyme Inc | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Insmed, Inc. | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$124
How this compares
$3,562 in reported general payments places this provider in the 85th percentile of 1,498 internal medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $15,745 |
| Levothyroxine Sodium | 40 | $398 |
| Omeprazole | 22 | $342 |
| Gabapentin | 22 | $334 |
| Amlodipine Besylate | 35 | $256 |
| Rosuvastatin Calcium | 23 | $236 |
| Duloxetine Hcl | 17 | $228 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 27 | $209 |
| Atorvastatin Calcium | 25 | $195 |
| Lovastatin | 17 | $194 |
| Metformin Hcl ErMetformin Hcl | 12 | $188 |
| Fluticasone Propionate | 14 | $187 |
| Losartan Potassium | 12 | $143 |
| Finasteride | 12 | $125 |
| Pantoprazole Sodium | 22 | $122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $211 | $15,74522 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $18 | $39840 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Anderson
- Carl SofleyAnderson$673K
- Anita VagnoniAnderson$21K
- Rica SantiagoMt Pleasant$10.7M
- Richard MillsMt Pleasant$5.5M
- Yvonne DavisMount Pleasant$2.4M
- David BolsterSummerville$2.3M
- Colby GrossmanSummerville$1.4M
- Amit ShahIndian Land$1.4M
- Philip NicolMurrells Inlet$782K
- Carl MitchellColumbia$564K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.